Distributions of CYP1A2 rs2069514 and rs762551 polymorphisms by ICU and Mortality Status
| Intensive Care | Mortality | |||||
|---|---|---|---|---|---|---|
| No | Yes | Alive | Ex | |||
| CYP1A2 (rs2069514) | Genotype n (%) | AA | 2 (5.7) | 4 (16.0) | 3 (6.4) | 3 (23.1) |
| AG | 3 (8.6) | 11 (44.0) | 7 (14.9) | 7 (53.8) | ||
| GG | 30 (85.7) | 10 (40.0) | 37 (78.7) | 3 (23.1) | ||
| Allele frequency, n (%) | A | 11 (14.8) | 19 (38.0) | 13 (13.8) | 13 (50.0) | |
| G | 63 (85.2) | 31 (62.0) | 81 (86.2) | 13 (50.0) | ||
| CYP1A2 (rs762551) | Genotype n (%) | AA | 16 (45.7) | 5 (20.0) | 18 (38.3) | 3 (23.1) |
| AC | 10 (28.6) | 5 (20.0) | 12 (25.5) | 3 (23.1) | ||
| CC | 9 (25.7) | 15 (60.0) | 17 (36.2) | 7 (53.8) | ||
| Allele frequency, n (%) | A | 42 (59.9) | 15 (30,0) | 48 (51.1) | 9 (34.6) | |
| C | 28 (40.1) | 35 (70.0) | 46 (48.9) | 17 (65.4) | ||
Distribution of age, gender, additional disease, and symptom information of patients with COVID-19 (n=60)
| Variables | N (%) | |
|---|---|---|
| Age | <65 | 29 (48.3) |
| ≥65 | 31 (51.7) | |
| Gender | Male | 32 (53.3) |
| Female | 28 (46.7) | |
| Chronic Disease | No | 38 (63.3) |
| Yes | 22 (36.7) | |
| Cardiovascular Disease | No | 47 (78.3) |
| Yes | 13 (21.7) | |
| Respiratory Distress | No | 39 (65.0) |
| Yes | 21 (35.0) | |
| Neurological Disease | No | 54 (90.0) |
| Yes | 6 (10.0) | |
| Fever | No | 50 (83.3) |
| Yes | 10 (16.7) | |
| Fatigue | No | 33 (55.0) |
| Yes | 27 (45.0) | |
| Cough | No | 37 (61.7) |
| Yes | 23 (38.3) | |
| Loss of Taste and Smell | No | 50 (83.3) |
| Yes | 10 (16.7) | |
| Diarrhea | No | 59 (98.3) |
| Yes | 1 (1.7) | |
| Nausea Vomiting | No | 56 (93.3) |
| Yes | 4 (6.7) | |
| Intubated | No | 45 (75.0) |
| Yes | 15 (25.0) | |
| Expectoration | No | 60 (100.0) |
| Yes | 0 (0,0) | |
| Frosted Glass Image | No | 40 (66.7) |
| Yes | 20 (33.3) | |
| Mortality | Alive | 47 (78.3) |
| Ex | 13 (21.7) | |
| Intensive Care | Alive | 35 (58.3) |
| Passed away | 25 (41.7) |
Comparison of patients with and without intensive care
| Intensive Care Hospitalization | |||
|---|---|---|---|
| Parameters, n (%) | Yes | No | p |
| Age | |||
| <65 | 5 (17.2) | 24 (82.8) | <0.001a |
| ≥65 | 20 (64.5) | 11 (35.5) | |
| Gender | |||
| Male | 15 (60.0) | 17 (48.6) | 0.382a |
| Woman | 10 (40.0) | 18 (51.4) | |
| Chronic Disease | |||
| No | 10 (26.3) | 28 (73.7) | 0.002a |
| Yes | 15 (68.2) | 7 (31.8) | |
| Cardiovascular Disease | |||
| No | 15 (31.9) | 32 (68.1) | 0.004a |
| Yes | 10 (76.9) | 3 (23.1) | |
| Respiratory Distress | |||
| No | 5 (12.8) | 34 (87.2) | <0.001a |
| Yes | 20 (95.2) | 1 (4.8) | |
| Neurological Disease | |||
| No | 19 (35.2) | 35 (64.8) | 0.004b |
| Yes | 6 (100.0) | 0 (0,0) | |
| Fever | |||
| No | 20 (40.0) | 30 (60.0) | 0.558b |
| Yes | 5 (50.0) | 5 (50.0) | |
| Cough | |||
| No | 13 (35.1) | 24 (64.9) | 0.193a |
| Yes | 12 (52.2) | 11 (47.8) | |
| Weakness | |||
| No | 10 (30.3) | 23 (69.7) | 0.048a |
| Yes | 15 (55.6) | 12 (44.4) | |
| Loss of Taste and Smell | |||
| No | 25 (50.0) | 25 (50.0) | 0.003b |
| Yes | 0 (0,0) | 10 (100.0) | |
| Diarrhea | |||
| No | 24 (40.7) | 35 (59.3) | 0.417b |
| Yes | 1 (100.0) | 0 (0,0) | |
| Nausea Vomiting | |||
| No | 21 (37.5) | 35 (62.5) | 0.026b |
| Yes | 4 (100.0) | 0 (0,0) | |
| Intubated | |||
| No | 10 (22.2) | 35 (77.8) | <0.001a |
| Yes | 15 (100.0) | 0 (0,0) | |
| Frosted Glass Image | |||
| No | 6 (15.0) | 34 (85.0) | <0.001a |
| Yes | 19 (95.0) | 1 (5.0) | |
| CYP1A2 rs2069514 | |||
| GG | 10 (25.0) | 30 (75.0) | <0.001a |
| AA+AG | 15 (75.0) | 5 (25.0) | |
| CYP1A2 rs762551 | |||
| AA | 5 (23.8) | 16 (76.2) | 0.040a |
| CC+CA | 20 (51.3) | 19 (48.7) | |
| CYP1A2 Genotype | |||
| *1A/*1A | 5 (55.6) | 4 (44.4) | <0.001a |
| *1A/*1F+*1F/*1F | 5 (16.1) | 26 (83.9) | |
| *1C/*1F | 4 (100.0) | 0 (0,0) | |
| *1A/*1C+*1C/*1C | 11 (68.8) | 5 (31.3) | |
Multivariate Logistic Regression Results on ICU Admission for Various Variables_
| Multivariate | ||
|---|---|---|
| Variables | OR (95%CI) | p |
| CYP1A2 Genotype (ref: *1A/*1A+*1F/*1F) | 5.23 (1.22–22.36) | 0.025 |
| Chronic disease (ref: none) | 4.68 (1.14–19.15) | 0.032 |
| Fatigue (ref: none) | 0.92 (0.21–3.94) | 0.920 |
| Age (ref: <65) | 5.17 (1.26–21.14) | 0.022 |
| R2 =0.48 −2 Log likelihood =55.201 | ||